{"id":52187,"date":"2025-12-29T20:22:50","date_gmt":"2025-12-29T12:22:50","guid":{"rendered":"https:\/\/flcube.com\/?p=52187"},"modified":"2025-12-29T20:22:51","modified_gmt":"2025-12-29T12:22:51","slug":"nmpa-releases-2025-priority-approval-directory-for-eight-high-end-medical-device-categories","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=52187","title":{"rendered":"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories"},"content":{"rendered":"\n

China\u2019s National Medical Products Administration (NMPA)<\/strong> published the 2025 Edition of the Directory of High-End Medical Devices Eligible for Priority Approval<\/strong>, designating eight breakthrough device categories<\/strong>\u2014including Boron Neutron Capture Therapy (BNCT) systems<\/strong>, implantable Brain-Computer Interfaces (BCI)<\/strong>, and transcatheter tricuspid valve systems<\/strong>\u2014for accelerated regulatory review, a move aimed at fast\u2011tracking innovation and reducing dependency on imported technologies.<\/p>\n\n\n\n

Regulatory Milestone<\/h2>\n\n\n\n
Item<\/th>Detail<\/th><\/tr><\/thead>
Regulator<\/strong><\/td>NMPA (Center for Medical Device Evaluation)<\/td><\/tr>
Policy<\/strong><\/td>Priority approval pathway for high-end medical devices (2025 Edition)<\/td><\/tr>
Device Categories Listed<\/strong><\/td>8 breakthrough technologies<\/td><\/tr>
Publication Date<\/strong><\/td>26\u202fDec\u202f2025<\/td><\/tr>
Impact<\/strong><\/td>30\u201150% reduction in review timeline; eligibility for parallel consultation & rolling submission<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Eligible High-End Medical Devices (2025 Edition)<\/h2>\n\n\n\n
Device Category<\/th>Technical Specifications \/ Intended Use<\/th>Market Significance<\/th><\/tr><\/thead>
Boron Neutron Capture Therapy (BNCT) System<\/strong><\/td>Utilizes neutron\u2011boron capture reaction to generate lethal secondary particles for recurrent\/malignant tumors with no conventional treatment options<\/td>First\u2011in\u2011class cancer therapy<\/strong>; addresses untreatable malignancies<\/td><\/tr>
Ultra\u2011High Field MRI Equipment<\/strong><\/td>Magnetic field strength \u22655T<\/td>Enables sub\u2011millimeter resolution<\/strong> for neuro-oncology and cardiac imaging<\/td><\/tr>
Medical Electron Accelerator<\/strong><\/td>Accelerator integrated with MRI guidance<\/strong> for real\u2011time adaptive radiotherapy<\/td>Theranostics fusion<\/strong>; precision radiation delivery<\/td><\/tr>
Implantable Brain\u2011Computer Interface (BCI) Medical Devices<\/strong><\/td>Obtains CNS neural signals via implantable electrodes; decodes signals for external device control or closed\u2011loop neuromodulation; for motor\/sensory\/speech disability compensation or neurological\/psychiatric disorder intervention<\/td>Neurotechnology frontier<\/strong>; targets paralysis, epilepsy, depression<\/td><\/tr>
Endoscopic Surgical Control System<\/strong><\/td>Robotic master\u2011slave control for digestive tract surgery via natural orifices<\/td>NOTES surgery<\/strong> (Natural Orifice Transluminal Endoscopic Surgery)<\/td><\/tr>
Transcatheter Tricuspid Valve Replacement\/Repair Systems<\/strong><\/td>For severe tricuspid regurgitation in high\u2011risk patients unsuitable for open surgery<\/td>Large unmet need<\/strong>; ~500,000 eligible patients in China<\/td><\/tr>
Implantable Glaucoma Drainage Devices for MIGS<\/strong><\/td>Minimally Invasive Glaucoma Surgery (MIGS) devices establishing aqueous humor drainage channels<\/td>Micro\u2011invasive solution<\/strong>; reduces intraocular pressure with fewer complications<\/td><\/tr>
Membrane Oxygenators (for ECMO)<\/strong><\/td>Used for gas exchange in respiratory\/circulatory failure patients; limited to<\/strong>: 1) Domestic neonatal\/child products; 2) Products using domestic hollow fiber modules; 3) Products using hollow fiber membranes from domestic pellets<\/td>Strategic import substitution<\/strong>; critical for pandemic preparedness<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Market Impact & Strategic Rationale<\/h2>\n\n\n\n

China High\u2011End Device Market Size<\/strong>: \u00a5420\u202fbillion<\/strong> (\u2248\u202fUS$58\u202fbillion) in 2025, growing at 14% CAGR<\/strong>, but 60\u201170% dependent<\/strong> on imported systems in the eight listed categories.<\/p>\n\n\n\n

Key Policy Objectives<\/strong>:<\/p>\n\n\n\n

    \n
  1. Innovation Catalyst<\/strong>: Fast\u2011track domestic breakthroughs to market within 12\u201118 months<\/strong> (vs. 24\u201136 months standard)<\/li>\n\n\n\n
  2. Import Substitution<\/strong>: ECMO membrane oxygenator criteria explicitly favor domestic supply chain<\/strong> self\u2011sufficiency<\/li>\n\n\n\n
  3. Patient Access<\/strong>: Priority devices receive reimbursement fast\u2011track<\/strong> under DRG\/DIP reforms<\/li>\n\n\n\n
  4. Global Competitiveness<\/strong>: BNCT and BCI approvals could position China as a first\u2011mover<\/strong> in neuro\u2011oncology and neuroprosthetics<\/li>\n<\/ol>\n\n\n\n

    Industry Response<\/strong>: Domestic manufacturers including Neusoft Medical<\/strong> (MRI), MicroPort<\/strong> (tricuspid valve), and Suzhou Weibond<\/strong> (ECMO) have confirmed alignment with the new criteria and expect IND\u2011equivalent submissions<\/strong> by Q2\u202f2026.<\/p>\n\n\n\n

    Regulatory Pathway & Timeline<\/h2>\n\n\n\n
    Stage<\/th>Standard Timeline<\/th>Priority Timeline<\/th>Savings<\/th><\/tr><\/thead>
    Innovation Approval<\/strong><\/td>90 days<\/td>30 days<\/td>60 days<\/td><\/tr>
    Registration Review<\/strong><\/td>180 days<\/td>90 days<\/td>90 days<\/td><\/tr>
    Reimbursement Listing<\/strong><\/td>12\u201118 months post\u2011approval<\/td>6\u20119 months<\/td>6\u20119 months<\/td><\/tr>
    Total Time\u2011to\u2011Market<\/strong><\/td>24\u201136 months<\/td>12\u201118 months<\/strong><\/td>12\u201118 months<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

    Devices meeting three or more<\/strong> criteria (e.g., domestic production, orphan indication, breakthrough technology) may qualify for breakthrough device designation<\/strong>, enabling rolling review<\/strong> and real\u2011world evidence (RWE) acceptance<\/strong>.<\/p>\n\n\n\n

    Forward\u2011Looking Statements<\/strong>
    This brief includes forward\u2011looking estimates regarding NMPA review timelines, domestic manufacturer market share gains, and revenue potential for priority\u2011listed device categories. Actual results may differ due to clinical validation requirements, competitive dynamics, and evolving reimbursement policies..<\/a>-Fineline Info & Tech<\/a><\/p>\n\n\n\n

    1766731514334051086<\/a>Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

    China\u2019s National Medical Products Administration (NMPA) published the 2025 Edition of the Directory of High-End…<\/p>\n","protected":false},"author":1,"featured_media":52189,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[80],"class_list":["post-52187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-priority-reviews"],"yoast_head":"\nNMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China\u2019s National Medical Products Administration (NMPA) published the 2025 Edition of the Directory of High-End Medical Devices Eligible for Priority Approval, designating eight breakthrough device categories\u2014including Boron Neutron Capture Therapy (BNCT) systems, implantable Brain-Computer Interfaces (BCI), and transcatheter tricuspid valve systems\u2014for accelerated regulatory review, a move aimed at fast\u2011tracking innovation and reducing dependency on imported technologies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=52187\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories\" \/>\n<meta property=\"og:description\" content=\"China\u2019s National Medical Products Administration (NMPA) published the 2025 Edition of the Directory of High-End Medical Devices Eligible for Priority Approval, designating eight breakthrough device categories\u2014including Boron Neutron Capture Therapy (BNCT) systems, implantable Brain-Computer Interfaces (BCI), and transcatheter tricuspid valve systems\u2014for accelerated regulatory review, a move aimed at fast\u2011tracking innovation and reducing dependency on imported technologies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=52187\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-29T12:22:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-29T12:22:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2902-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories\",\"datePublished\":\"2025-12-29T12:22:50+00:00\",\"dateModified\":\"2025-12-29T12:22:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187\"},\"wordCount\":571,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/2902-1.webp\",\"keywords\":[\"Priority reviews\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52187#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=52187\",\"name\":\"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/2902-1.webp\",\"datePublished\":\"2025-12-29T12:22:50+00:00\",\"dateModified\":\"2025-12-29T12:22:51+00:00\",\"description\":\"China\u2019s National Medical Products Administration (NMPA) published the 2025 Edition of the Directory of High-End Medical Devices Eligible for Priority Approval, designating eight breakthrough device categories\u2014including Boron Neutron Capture Therapy (BNCT) systems, implantable Brain-Computer Interfaces (BCI), and transcatheter tricuspid valve systems\u2014for accelerated regulatory review, a move aimed at fast\u2011tracking innovation and reducing dependency on imported technologies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52187\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/2902-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/2902-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52187#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories - Insight, China's Pharmaceutical Industry","description":"China\u2019s National Medical Products Administration (NMPA) published the 2025 Edition of the Directory of High-End Medical Devices Eligible for Priority Approval, designating eight breakthrough device categories\u2014including Boron Neutron Capture Therapy (BNCT) systems, implantable Brain-Computer Interfaces (BCI), and transcatheter tricuspid valve systems\u2014for accelerated regulatory review, a move aimed at fast\u2011tracking innovation and reducing dependency on imported technologies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=52187","og_locale":"en_US","og_type":"article","og_title":"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories","og_description":"China\u2019s National Medical Products Administration (NMPA) published the 2025 Edition of the Directory of High-End Medical Devices Eligible for Priority Approval, designating eight breakthrough device categories\u2014including Boron Neutron Capture Therapy (BNCT) systems, implantable Brain-Computer Interfaces (BCI), and transcatheter tricuspid valve systems\u2014for accelerated regulatory review, a move aimed at fast\u2011tracking innovation and reducing dependency on imported technologies.","og_url":"https:\/\/flcube.com\/?p=52187","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-29T12:22:50+00:00","article_modified_time":"2025-12-29T12:22:51+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2902-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=52187#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=52187"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories","datePublished":"2025-12-29T12:22:50+00:00","dateModified":"2025-12-29T12:22:51+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=52187"},"wordCount":571,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=52187#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2902-1.webp","keywords":["Priority reviews"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=52187#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=52187","url":"https:\/\/flcube.com\/?p=52187","name":"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=52187#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=52187#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2902-1.webp","datePublished":"2025-12-29T12:22:50+00:00","dateModified":"2025-12-29T12:22:51+00:00","description":"China\u2019s National Medical Products Administration (NMPA) published the 2025 Edition of the Directory of High-End Medical Devices Eligible for Priority Approval, designating eight breakthrough device categories\u2014including Boron Neutron Capture Therapy (BNCT) systems, implantable Brain-Computer Interfaces (BCI), and transcatheter tricuspid valve systems\u2014for accelerated regulatory review, a move aimed at fast\u2011tracking innovation and reducing dependency on imported technologies.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=52187#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=52187"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=52187#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2902-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2902-1.webp","width":1080,"height":608,"caption":"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=52187#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NMPA Releases 2025 Priority Approval Directory for Eight High-End Medical Device Categories"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2902-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52187"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52187\/revisions"}],"predecessor-version":[{"id":52191,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52187\/revisions\/52191"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/52189"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=52187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=52187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}